| Primary |
| Hypertension |
26.3% |
| Product Used For Unknown Indication |
26.3% |
| Anxiety |
10.5% |
| Atrial Fibrillation |
10.5% |
| Blood Pressure |
5.3% |
| Heart Rate Irregular |
5.3% |
| Palpitations |
5.3% |
| Supraventricular Extrasystoles |
5.3% |
| Ventricular Tachycardia |
5.3% |
|
| Pharmaceutical Product Complaint |
10.0% |
| Product Substitution Issue |
10.0% |
| Renal Failure |
10.0% |
| Shock |
10.0% |
| Bradycardia |
5.0% |
| Drug Dispensing Error |
5.0% |
| Drug Ineffective |
5.0% |
| Drug Toxicity |
5.0% |
| Inadequate Analgesia |
5.0% |
| Multi-organ Failure |
5.0% |
| No Adverse Event |
5.0% |
| Pain In Extremity |
5.0% |
| Product Quality Issue |
5.0% |
| Therapeutic Agent Toxicity |
5.0% |
| Toxicity To Various Agents |
5.0% |
| Vomiting |
5.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
29.2% |
| Hypertension |
14.0% |
| Ischaemic Cardiomyopathy |
8.1% |
| Thrombosis Prophylaxis |
7.1% |
| Foetal Exposure During Pregnancy |
6.2% |
| Anxiety |
4.5% |
| Product Used For Unknown Indication |
3.9% |
| Hypothyroidism |
3.6% |
| Vitamin D Deficiency |
3.6% |
| Atrial Fibrillation |
2.6% |
| Infarction |
2.6% |
| Renal Transplant |
2.6% |
| Cardiac Failure |
1.9% |
| Type 2 Diabetes Mellitus |
1.9% |
| Diabetes Mellitus Non-insulin-dependent |
1.6% |
| Myocardial Infarction |
1.6% |
| Coronary Artery Disease |
1.3% |
| Diabetes Mellitus |
1.3% |
| Pain |
1.3% |
| Hypercholesterolaemia |
1.0% |
|
| Toxic Skin Eruption |
16.7% |
| Renal Failure |
9.3% |
| Sepsis |
9.3% |
| Vomiting |
9.3% |
| Orthostatic Hypotension |
7.4% |
| Malaise |
5.6% |
| Renal Failure Acute |
5.6% |
| Tachypnoea |
5.6% |
| Tendon Rupture |
5.6% |
| Hypoglycaemia |
3.7% |
| Lupus-like Syndrome |
3.7% |
| Urine Arsenic Increased |
3.7% |
| Angioedema |
1.9% |
| Brain Death |
1.9% |
| Chest Discomfort |
1.9% |
| Congenital Renal Cyst |
1.9% |
| Drug Toxicity |
1.9% |
| Ear Malformation |
1.9% |
| Fall |
1.9% |
| Folliculitis |
1.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
22.6% |
| Product Used For Unknown Indication |
20.4% |
| Hypertension |
14.5% |
| Urinary Tract Infection |
6.9% |
| Rheumatoid Arthritis |
5.7% |
| Prophylaxis |
4.3% |
| Pain |
3.4% |
| Pulmonary Embolism |
2.5% |
| Osteoporosis |
2.5% |
| Atrial Fibrillation |
2.3% |
| Cardiac Disorder |
2.1% |
| Diabetes Mellitus |
2.0% |
| Type 2 Diabetes Mellitus |
2.0% |
| Depression |
1.6% |
| Multiple Myeloma |
1.3% |
| Non-small Cell Lung Cancer |
1.3% |
| Hypercholesterolaemia |
1.2% |
| Thrombosis Prophylaxis |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Coronary Artery Disease |
1.1% |
|
| White Blood Cell Count Increased |
16.0% |
| Renal Failure Acute |
9.1% |
| Vomiting |
8.7% |
| Myocardial Infarction |
6.8% |
| Renal Failure |
6.8% |
| Weight Decreased |
5.9% |
| Nausea |
5.0% |
| Death |
4.1% |
| Hyponatraemia |
3.7% |
| Pyrexia |
3.7% |
| Thrombocytopenia |
3.7% |
| Transient Ischaemic Attack |
3.7% |
| Pain In Extremity |
3.2% |
| Sepsis |
3.2% |
| Transaminases Increased |
3.2% |
| Neuropathy Peripheral |
2.7% |
| Pancreatitis Acute |
2.7% |
| Skin Plaque |
2.7% |
| Wrist Fracture |
2.7% |
| Condition Aggravated |
2.3% |
|
| Interacting |
| Drug Use For Unknown Indication |
81.8% |
| Pulmonary Embolism |
9.1% |
| Type 2 Diabetes Mellitus |
9.1% |
|
| Hypoglycaemia |
50.0% |
| White Blood Cell Count Increased |
50.0% |
|
